Lower riskMedical device recall · FDA · Published September 14, 2020
Bard 3F SL PowerMidline Kit Recall: Missing Stylet May Cause Procedural Delays
Becton Dickinson recalls Bard 3F SL PowerMidline Full Kits due to missing stylet/T-lock assembly, which could lead to procedural delays or kit discards during IV procedures.
“Bard 3F SL PowerMidline Kit Recall: Missing Stylet May Cause Procedural Delays.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/64289-bard-3f-sl-powermidline-kit-recall-missing-stylet-may-cause. Based on FDA recall #Z-0295-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0295-2021%22&limit=1).
Becton Dickinson & Company voluntarily recalled Bard 3F SL PowerMidline Full Kits on Sept. 14, 2020, according to the FDA. The kits lack the labeled stylet/T-lock assembly, which may cause procedural delays and kit discard.
How to tell if you have it
Brand: Becton Dickinson
Product: Bard 3F SL PowerMidline Full Kit CE-indicated for short term access to the peripheral venous system
Lot Numbers: REEQ3598 (Feb-2022), REER0518 (Mar-2022)
UDI: 00801741141065
Quantity: 72 units
Distribution: Italy, Spain, and UK
The hazard
The kits do not contain the stylet/T-lock assembly indicated as a component on the label. This omission may lead to a procedural delay and possibly discard of the kit.
Context
GovInfoNow's records show Becton Dickinson & Company has 52 other recalls on record since May 31, 2017. Other recent recalls include the Jan. 27, 2026 recall of 10mL Non-Sterile Luer-Lok Syringes due to wrong syringe type and the Oct. 14, 2025 recall of Luer Tip Caps for failed biocompatibility testing. Similar product recalls include the Nov. 6, 2025 Bard Ureteral Stent Kit recall for label size mismatch risk and the May 21, 2026 Bard PowerMidline Catheter recalls regarding deficient lidocaine ampoule manufacturing.
How to tell if you have this one
Check for the Bard 3F SL PowerMidline Full Kit with lot numbers REEQ3598 (Feb 2022) or REER0518 (Mar 2022). The kit is CE-indicated for short-term IV access.
Brand
Becton Dickinson
Category
Medical device
FDA recall event · 2 products
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
Classification
Class II
Status
Terminated
Distribution
Foreign: Italy, Spain, and UK
Recall number
Product, codes & lots
Quantity
Z-0294-2021
Bard 3F SL PowerMidline Basic Kit CE-indicated for short term access to the peripheral venous system for selected intravenous therapies, blood sampling, and power injection of contrast media Ref: P6153118; Lot Number: REEP2920 Exp. Date: Jan-2022 UDI: 00801741141027
45 units OUS only
Z-0295-2021
Bard 3F SL PowerMidline Full Kit CE-indicated for short term access to the peripheral venous system for selected intravenous therapies, blood sampling, and power injection of contrast media Ref: P6153208; Lot Number: REEQ3598 Feb-2022 and REER0518 Mar-2022 UDI: 00801741141065
72 units
Based on the official FDA remedy
What to do — step by step
Check Kit Contents
Verify that the kit includes the stylet/T-lock assembly listed on the label.
How this recall unfolded
Recall timeline
FDA terminated this recall 14 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0295-2021 (September 14, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0295-2021 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.